Articles From: Luminex Corporation To Present At Upcoming Investment Conferences to Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer


2013/5/7
AUSTIN, Texas , May 7, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that management will present at three upcoming investment conferences: The UBS Global Healthcare Conference on Tuesday, May 21 at 1pm ET in New York City The Jefferies 2013 Global Healthcare Conference on Tuesday, June 4 at 1:30pm ET in New York City , and The Goldman Sachs 34 th Annual Global Healthcare Conference on Tuesday, June 11 at 1:20pm PT in Rancho Palos Verdes    The presentations will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com .
Sign-up for Luminex Corporation To Present At Upcoming Investment Conferences investment picks
2013/5/7
MCLEAN, Va.
Sign-up for SAIC to Hold Annual Meeting of Stockholders on June 7, 2013 investment picks
2013/5/7
http://media.marketwire.com/attachments/200810/472497_Salemlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014280&ProfileId=051205&sourceType=1 CAMARILLO, CA --
Sign-up for Salem Communications Announces Increase in First Quarter 2013 Total Revenue of 2.5% to $55.6 Million investment picks
2013/5/7
http://media.marketwire.com/attachments/200709/365332_biologo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014773&ProfileId=051205&sourceType=1 IRVINE, CA --
Sign-up for BIOLASE Reports 2013 First Quarter Results investment picks
2013/5/7
Company Reports Total Revenues of $196 Million Driven by Record Net Sales of Xyrem and Erwinaze Adjusted EPS of $1.37; GAAP EPS of $0.71 Company Announces up to $200 Million Share Repurchase Program DUBLIN , May 7, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter ended March 31, 2013 , updated 2013 financial guidance and key additions to its board of directors.
Sign-up for JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2013 FINANCIAL RESULTS investment picks
2013/5/7
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today reported its financial and operating results for the quarter ended March 31, 2013.
Sign-up for Furiex Reports First Quarter 2013 Financial Results investment picks
2013/5/7
Synageva BioPharma Corp.
Sign-up for Synageva BioPharma™ Reports First Quarter 2013 Financial Results investment picks
2013/5/7
http://media.marketwire.com/attachments/201101/19038_verisignlogoresized.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014652&ProfileId=051205&sourceType=1 RESTON, VA --
Sign-up for Verisign to Present at the J.P. Morgan Global Technology, Media and Telecom Conference investment picks
2013/5/7
FARMINGTON, Conn., May 7, 2013 (GLOBE NEWSWIRE) -- Horizon Technology Finance Corporation (Nasdaq:HRZN) (the "Company" or "Horizon"), a leading specialty finance company that provides secured loans to venture capital and private equity-backed development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, today announced its first quarter financial results for the three months ended March 31, 2013.
Sign-up for Horizon Technology Finance Announces First Quarter 2013 Financial Results investment picks
2013/5/7
SALT LAKE CITY, May 7, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its third fiscal quarter and nine months ended March 31, 2013.
Sign-up for Myriad Genetics Reports Third Quarter Fiscal Year 2013 Results investment picks
2013/5/7
Seattle Genetics, Inc. (Nasdaq: SGEN) today reported financial results for the first quarter ended March 31, 2013.
Sign-up for Seattle Genetics Reports First Quarter 2013 Financial Results investment picks
2013/5/7
United Natural Foods, Inc. (Nasdaq: UNFI) (the "Company") today announced that Mark Shamber, Senior Vice President, Chief Financial Officer and Treasurer, will present at the BMO Farm to Market Conference Tuesday, May 14, 2013 at 2:30 pm ET in New York, NY.
Sign-up for United Natural Foods to Present at the BMO Farm to Market Conference investment picks
2013/5/7
Hampden Bancorp, Inc. (the “Company”) (NASDAQ - HBNK), which is the holding company for Hampden Bank (the “Bank”), announced the results of operations for the three and nine months ended March 31, 2013.
Sign-up for Hampden Bancorp, Inc. Reports a 12% Increase in Nine Month Net Income and Declares Cash Dividend investment picks
2013/5/7
The Hackett Group, Inc. (NASDAQ: HCKT) , a global strategic advisory and business transformation consulting firm, today announced its financial results for the first quarter, which ended March 29, 2013.
Sign-up for The Hackett Group Announces First Quarter 2013 Results investment picks
2013/5/7
Demand Media, Inc. (NYSE: DMD) , a leading digital media and domain services company, today reported financial results for the first quarter ended March 31, 2013.
Sign-up for Demand Media Reports First Quarter 2013 Results investment picks
2013/5/7
CA Technologies (NASDAQ:CA) today reported financial results for its fourth quarter and full fiscal year 2013, ended March 31, 2013.
Sign-up for CA Technologies Reports Fourth Quarter and Full Fiscal Year 2013 Results investment picks
2013/5/7
Company Management in Conjunction With Expanded Board of Directors Reviews Company's Strategy, Assets and Investment and Spending Plans Mississippian Quarterly Production Grew to 39.5 MBoe per Day (46% Oil), a 10% Increase from the Previous Period and a 105% Increase over the First Quarter of 2012 Brought on 109 Mississippian Wells with an Average 30-day IP of 330 Boe per Day during the First Quarter Issues Revised 2013 Guidance, a 33% Reduction in Capital Expenditures from 2012 - Estimated Total Production of 32.7 MMBoe - Estimated Mississippian Production of 16.2 MMBoe, 60% Growth - Planned Capital Expenditures of $1.45 Billion, $700 Million Decrease from 2012 OKLAHOMA CITY , May 7, 2013 /PRNewswire/ -- SandRidge Energy, Inc. (NYSE: SD) today announced financial and operational results for the quarter ended March 31, 2013 .
Sign-up for SandRidge Energy, Inc. Reports Financial and Operational Results for the First Quarter of 2013 investment picks
2013/5/7
NEW YORK, May 7, 2013 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq:NYMT) ("NYMT," the "Company," "we," "our" or "us") today reported results for the three months ended March 31, 2013.
Sign-up for New York Mortgage Trust Reports First Quarter 2013 Results investment picks
2013/5/7
Primerica, Inc. (NYSE: PRI) announced today financial results for the first quarter ended March 31, 2013.
Sign-up for Primerica Reports First Quarter 2013 Results investment picks
2013/5/7
Equinix, Inc. (Nasdaq: EQIX) , the global interconnection and data center company, today announced the company will present at International Telecoms Week (ITW) 2013, being held May 13-15, 2013, in Chicago, IL.
Sign-up for Media Alert: Equinix and Partners to Lead Cloud Panel Discussion at ITW 2013 investment picks
2013/5/7
HOUSTON , May 7, 2013 /PRNewswire/ -- Carriage Services, Inc. (NYSE: CSV) today announced record results for the quarter ending March 31, 2013 .
Sign-up for Carriage Services Announces Record Results For First Quarter 2013 investment picks
2013/5/7
Terreno Realty Corporation (NYSE:TRNO) , an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, announced today the promotion of Jaime J.
Sign-up for Terreno Realty Corporation Announces Promotion of Jaime J. Cannon to CFO investment picks
2013/5/7
HOUSTON , May 7, 2013 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME) , a nutritional product company and a leading integrated producer of omega-3 fish oil and specialty protein products, today announced results for the first quarter ended March 31 , 2013.
Sign-up for Omega Protein Announces First Quarter 2013 Financial Results investment picks
2013/5/7
Sucampo Pharmaceuticals, Inc. (“Sucampo”) (NASDAQ: SCMP) , a global pharmaceutical company with products available in the United States (U.S.), Japan and Europe, today reported its consolidated financial results for the first quarter ended March 31, 2013.
Sign-up for Sucampo Pharmaceuticals, Inc. Reports First Quarter 2013 Financial and Operating Results investment picks
2013/5/7
Chatham Lodging Trust (NYSE: CLDT) , a hotel real estate investment trust (REIT) that owns wholly or through its joint venture approximately $1.5 billion of premium-branded, upscale, extended-stay and select-service hotels, today announced results for the quarter ended March 31, 2013.
Sign-up for Chatham Lodging Trust Announces Strong 2013 First Quarter Results investment picks
2013/5/7
URS Corporation (NYSE: URS) today reported its financial results for the first quarter of fiscal 2013, which ended on March 29, 2013.
Sign-up for URS Corporation Reports First Quarter 2013 Results investment picks
2013/5/7
LA JOLLA, Calif.
Sign-up for Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call investment picks
2013/5/7
http://media.marketwire.com/attachments/201107/29861_konagrilllogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014715&ProfileId=051205&sourceType=1 SCOTTSDALE, AZ --
Sign-up for Kona Grill to Present at B. Riley's 14th Annual Investor Conference on May 22, 2013 investment picks
2013/5/7
SAO PAULO --Brazilian exporters are facing a major crunch when it comes to both cost and revenue, according to Murilo Ferreira, president of mining giant Vale (VALE5.BR, VALE), Brazil's largest single exporter.
Sign-up for Brazil Currency Still Overvalued From Exporter Perspective-Vale investment picks
2013/5/7
Study Meets Primary Endpoint of Non-Inferiority in Monotherapy Setting THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Luminex Corporation To Present At Upcoming Investment Conferences to Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity